- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Top CEOs, start-ups, fund managers, and scientists return to Cambridge, MA on October 16-17, 2006 for elite nanotechnology gathering
Lux Research, the world’s leading research and advisory firm for nanotechnology, today announced its second annual Lux Executive Summit: Commercializing Nanotechnology, to be held on October 16-17, 2006 at the Charles Hotel in Cambridge, Massachusetts.
“Last year’s Summit brought 250 nanotech leaders together for two intense days of learning, debate, and networking,” said Lux Research CEO Peter Hebert. “In response to attendee feedback, this year we’ll expand the event with more proprietary analysis from the Lux Research analyst team and a greater focus on cutting-edge start-ups and research labs. However, the Summit will maintain the exclusivity that made last year’s networking sessions such a great success.” Attendees and speakers at the previous Lux Executive Summit included CEOs of public and private companies, executives responsible for nanotech commercialization at leading corporations, venture capitalists and portfolio managers, scientific pioneers, and top policymakers. Organizations represented ranged from Johnson & Johnson to Credit Suisse to Harvard Business School.
Attendees at last year’s Lux Executive Summit praised the event:
"The Lux Executive Summit provides executives with unique insights into nanotechnology – and thus helps shape their development of successful business and product strategies."
– Norbert G. Riedel, Chief Scientific Officer, Baxter International Inc.
"There’s no better place to connect with the decision-makers who are committing dollars to nanotech. The Lux Executive Summit is the gathering place for nanotechnology's thought leaders."
– Stephen B. Maebius, Partner and Leader of Nanotechnology Industry Team, Foley & Lardner LLP
"The Lux Executive Summit provided frameworks for nanotechnology investing that you won't hear anywhere else – and applied them to real companies right now."
– Pip Coburn, Founder and CEO, Coburn Ventures
"This wasn’t an event; it was an experience."
– Stanley Jackson, Deputy Mayor for Planning and Economic Development, Washington, D.C.
"The Lux Executive Summit is a first class event – well organized, focused and important."
– Donald R. Young, President and CEO, Aspen Aerogels
The Lux Executive Summit is the only event designed to provide corporate executives and investment managers with the knowledge and insights required to create a visionary nanotechnology strategy. The event is grounded by the proprietary data and analysis from Lux Research’s world-renowned analyst team, joined onstage by more than 50 speakers from large corporations, innovative start-ups, forward-thinking investment management firms, and the public sector. The full agenda and confirmed speakers for the 2006 Lux Executive Summit will be released in the coming months. Capacity is limited at this premier event; additional details are available online at www.luxexecutivesummit.com
About Lux Research:
Lux Research is the world's leading nanotechnology research and advisory firm. We help our clients make better decisions to profit from nanoscale science and technology, tapping into our analysts' unique expertise and unrivaled network. Our clients include top decision makers at large corporations, portfolio managers and analysts at leading financial institutions, CEOs of the most innovative start-ups, and visionary public policy makers.
For Lux Executive Summit registration and additional event details, please visit www.luxexecutivesummit.com
For more information, please click here.Copyright © Lux Research
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Physicists solve quantum tunneling mystery: ANU media release: An international team of scientists studying ultrafast physics have solved a mystery of quantum mechanics, and found that quantum tunneling is an instantaneous process May 27th, 2015
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015